J Anim Sci Biotechnol. 2013 Oct 29;4(1):40. doi: 10.1186/2049-1891-4-40.

Culture conditions for equine bone marrow mesenchymal stem cells and expression of key transcription factors during their differentiation into osteoblasts.

Journal of animal science and biotechnology

Elizabeth R A Glynn, Alfredo Sanchez Londono, Steven A Zinn, Thomas A Hoagland, Kristen E Govoni

PMID: 24169030 PMCID: PMC3874597 DOI: 10.1186/2049-1891-4-40

Abstract

BACKGROUND: The use of equine bone marrow mesenchymal stem cells (BMSC) is a novel method to improve fracture healing in horses. However, additional research is needed to identify optimal culture conditions and to determine the mechanisms involved in regulating BMSC differentiation into osteoblasts. The objectives of the experiments were to determine: 1) if autologous or commercial serum is better for proliferation and differentiation of equine BMSC into osteoblasts, and 2) the expression of key transcription factors during the differentiation of equine BMSC into osteoblasts. Equine BMSC were isolated from the sterna of 3 horses, treated with purchased fetal bovine serum (FBS) or autologous horse serum (HS), and cell proliferation determined. To induce osteoblast differentiation, cells were incubated with L-ascorbic acid-2-phosphate and glycerol-2-phosphate in the presence or absence of human bone morphogenetic protein2 (BMP2), dexamethasone (DEX), or combination of the two. Alkaline phosphatase (ALP) activity, a marker of osteoblast differentiation, was determined by ELISA. Total RNA was isolated from differentiating BMSC between d 0 to 18 to determine expression of runt-related transcription factor2 (Runx2), osterix (Osx), and T-box3 (Tbx3). Data were analyzed by ANOVA.

RESULTS: Relative to control, FBS and HS increased cell number (133 ± 5 and 116 ± 5%, respectively; P < 0.001) and 5-bromo-2'-deoxyuridine (BrdU) incorporation (167 ± 6 and 120 ± 6%, respectively; P < 0.001). Treatment with DEX increased ALP activity compared with control (1,638 ± 38%; P < 0.001). In the absence and presence of Dex, BMP-2 did not alter ALP activity (P > 0.8). Runt-related transcription factor2 expression increased 3-fold (P < 0.001) by d 6 of culture. Osterix expression increased 9-fold (P < 0.05) by d 18 of culture. Expression of Tbx3 increased 1.8-fold at d 3 (P < 0.01); however expression was reduced 4-fold at d 18 (P < 0.01).

CONCLUSIONS: Dexamethasone, but not BMP-2, is required for differentiation of equine BMSC into osteoblasts. In addition, expression of Runx2 and osterix increased and expression of Tbx3 is reduced during differentiation.

References

1. Tissue Eng. 2002 Apr;8(2):321-31 - PubMed
2. Int J Dev Biol. 2008;52(8):1033-42 - PubMed
3. Cells Tissues Organs. 2009;189(1-4):144-52 - PubMed
4. Nat Protoc. 2008;3(6):1101-8 - PubMed
5. Vet Surg. 2006 Oct;35(7):601-10 - PubMed
6. Am J Physiol Endocrinol Metab. 2006 Jul;291(1):E128-36 - PubMed
7. J Am Vet Med Assoc. 1996 Jan 1;208(1):92-6 - PubMed
8. Am J Vet Res. 2007 Oct;68(10):1095-105 - PubMed
9. Endocrinology. 2001 Jul;142(7):2731-3 - PubMed
10. Semin Cell Dev Biol. 2008 Oct;19(5):459-66 - PubMed
11. J Cell Biochem. 2009 Feb 15;106(3):482-90 - PubMed
12. Cell Biol Int. 2009 May;33(5):607-16 - PubMed
13. Am J Vet Res. 2010 Oct;71(10):1237-45 - PubMed
14. Equine Vet J. 2003 Jan;35(1):99-102 - PubMed
15. J Bone Joint Surg Am. 2002 Dec;84(12):2123-34 - PubMed
16. Int Orthop. 2011 Sep;35(9):1271-80 - PubMed
17. J Cell Biochem. 1997 Feb;64(2):278-94 - PubMed
18. Curr Stem Cell Res Ther. 2008 May;3(2):131-45 - PubMed
19. Am J Vet Res. 2010 Jan;71(1):103-14 - PubMed
20. Can Vet J. 2008 Oct;49(10):1009-17 - PubMed
21. J Bone Miner Res. 1999 Jul;14(7):1115-22 - PubMed
22. Acta Chir Orthop Traumatol Cech. 2008 Aug;75(4):241-6 - PubMed
23. J Orthop Res. 2010 Oct;28(10):1330-7 - PubMed
24. Vet Clin North Am Equine Pract. 2011 Aug;27(2):299-314 - PubMed
25. Vet Surg. 2006 Apr;35(3):232-42 - PubMed

Publication Types

• Journal Article